BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17636719)

  • 1. WITHDRAWN: Etidronate for treating and preventing postmenopausal osteoporosis.
    Cranney A; Adachi JD; Griffith L; Guyatt G; Krolicki N; Robinson VA; Shea BJ; Wells G
    Cochrane Database Syst Rev; 2007 Jul; (1):CD003376. PubMed ID: 17636719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etidronate for treating and preventing postmenopausal osteoporosis.
    Cranney A; Welch V; Adachi JD; Guyatt G; Krolicki N; Griffith L; Shea B; Tugwell P; Wells G
    Cochrane Database Syst Rev; 2001; (4):CD003376. PubMed ID: 11687195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
    Cranney A; Guyatt G; Krolicki N; Welch V; Griffith L; Adachi JD; Shea B; Tugwell P; Wells G;
    Osteoporos Int; 2001; 12(2):140-51. PubMed ID: 11303715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.
    Cranney A; Adachi JD; Guyatt G; Papaioannou A; Robinson VA; Shea BJ; Tugwell P; Waldegger LM; Weaver B; Wells G; Zytaruk N
    Cochrane Database Syst Rev; 2007 Jul; (1):CD004523. PubMed ID: 17636764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risedronate for the prevention and treatment of postmenopausal osteoporosis.
    Cranney A; Waldegger L; Zytaruk N; Shea B; Weaver B; Papaioannou A; Robinson V; Wells G; Tugwell P; Adachi JD; Guyatt G
    Cochrane Database Syst Rev; 2003; (4):CD004523. PubMed ID: 14584020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
    Wells GA; Cranney A; Peterson J; Boucher M; Shea B; Robinson V; Coyle D; Tugwell P
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD003376. PubMed ID: 18254018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.
    Harris ST; Watts NB; Jackson RD; Genant HK; Wasnich RD; Ross P; Miller PD; Licata AA; Chesnut CH
    Am J Med; 1993 Dec; 95(6):557-67. PubMed ID: 8259772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
    O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etidronate and alendronate in the treatment of postmenopausal osteoporosis.
    Beauchesne MF; Miller PF
    Ann Pharmacother; 1999 May; 33(5):587-99. PubMed ID: 10369624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis.
    Cranney A; Tugwell P; Adachi J; Weaver B; Zytaruk N; Papaioannou A; Robinson V; Shea B; Wells G; Guyatt G;
    Endocr Rev; 2002 Aug; 23(4):517-23. PubMed ID: 12202466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis.
    Cranney A; Tugwell P; Zytaruk N; Robinson V; Weaver B; Shea B; Wells G; Adachi J; Waldegger L; Guyatt G;
    Endocr Rev; 2002 Aug; 23(4):540-51. PubMed ID: 12202469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
    Harris ST; Watts NB; Genant HK; McKeever CD; Hangartner T; Keller M; Chesnut CH; Brown J; Eriksen EF; Hoseyni MS; Axelrod DW; Miller PD
    JAMA; 1999 Oct; 282(14):1344-52. PubMed ID: 10527181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women.
    Papadimitropoulos E; Wells G; Shea B; Gillespie W; Weaver B; Zytaruk N; Cranney A; Adachi J; Tugwell P; Josse R; Greenwood C; Guyatt G;
    Endocr Rev; 2002 Aug; 23(4):560-9. PubMed ID: 12202471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WITHDRAWN: Calcium supplementation on bone loss in postmenopausal women.
    Shea B; Wells G; Cranney A; Zytaruk N; Robinson V; Griffith L; Hamel C; Ortiz Z; Peterson J; Adachi J; Tugwell P; Guyatt G; ;
    Cochrane Database Syst Rev; 2007 Jul; 2006(1):CD004526. PubMed ID: 17636765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.
    Watts NB; Harris ST; Genant HK; Wasnich RD; Miller PD; Jackson RD; Licata AA; Ross P; Woodson GC; Yanover MJ
    N Engl J Med; 1990 Jul; 323(2):73-9. PubMed ID: 2113611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium supplementation on bone loss in postmenopausal women.
    Shea B; Wells G; Cranney A; Zytaruk N; Robinson V; Griffith L; Hamel C; Ortiz Z; Peterson J; Adachi J; Tugwell P; Guyatt G; ;
    Cochrane Database Syst Rev; 2004; (1):CD004526. PubMed ID: 14974070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium supplementation on bone loss in postmenopausal women.
    Shea B; Wells G; Cranney A; Zytaruk N; Robinson V; Griffith L; Hamel C; Ortiz Z; Peterson J; Adachi J; Tugwell P; Guyatt G; ;
    Cochrane Database Syst Rev; 2003; (4):CD004526. PubMed ID: 14584022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of etidronate and calcium versus calcium alone in the treatment of postmenopausal osteopenia: results of three years of treatment.
    Montessori ML; Scheele WH; Netelenbos JC; Kerkhoff JF; Bakker K
    Osteoporos Int; 1997; 7(1):52-8. PubMed ID: 9102064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
    Wimalawansa SJ
    Am J Med; 1998 Mar; 104(3):219-26. PubMed ID: 9552083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women.
    Wells G; Tugwell P; Shea B; Guyatt G; Peterson J; Zytaruk N; Robinson V; Henry D; O'Connell D; Cranney A;
    Endocr Rev; 2002 Aug; 23(4):529-39. PubMed ID: 12202468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.